Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00471497
Title A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) (ENESTnd)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

chronic myeloid leukemia

Therapies

Nilotinib

Imatinib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUT

Facility Status City State Zip Country Details
University of California at Los Angeles Dept. of Hematology Clinic Los Angeles California 90095 United States Details
Kaiser Permanente - California Southern Dept of Kaiser South 3 San Diego California 92120 United States Details
Kaiser Permanente - California Northern Vallejo Med Center/Med Offices Vallejo California 94589 United States Details
Kaiser Permanente - California Northern Kaiser Med Vallejo California 94609 United States Details
Rocky Mountain Cancer Centers RMCC - Colorado Springs Greenwood Village Colorado United States Details
Florida Cancer Specialists Dept. FloridaCancerSpecialists Fort Myers Florida 33901 United States Details
Advanced Medical Specialties Research Dept. Miami Florida 33176 United States Details
Cancer Centers of Florida PA Cancer Centers of FL Ocoee Florida 34761 United States Details
Florida Retina Institute Flordia Cancer Affilates Orlando Florida 32804 United States Details
University of Chicago Section of Hematology/Oncology Chicago Illinois 60637 United States Details
Indiana Blood and Marrow Institute Dept. of Indiana Blood&Marrow Beech Grove Indiana 46107 United States Details
University of Iowa Hospitals and Clinics Dept.of U of Iowa Hosp&Clinics Iowa City Iowa 52242 United States Details
Kansas City Cancer Center KCCC Business Office Overland Park Kansas 66210 United States Details
LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center New Orleans Louisiana 70115 United States Details
Michigan State University / Breslin Cancer Center Breslin Cancer Center Lansing Michigan 48824 United States Details
Missouri Cancer Associates Dept. of Boone Hospital Center Columbia Missouri 65201 United States Details
Hematology Oncology Consultants, Inc. Deptof Hem. Onc.Consunsultants Saint Louis Missouri 63136 United States Details
Hackensack University Medical Center Department of Research Hackensack New Jersey 07601 United States Details
Memorial Sloan Kettering Cancer Center Clinical Trials Office New York New York 10021 United States Details
University of North Carolina UNC Lineberger Cancer Center Chapel Hill North Carolina 27514 United States Details
Wake Forest University Health Sciences Dept. of Industry Research Winston-Salem North Carolina 27157 United States Details
University of Cincinnati / Barrett Cancer Center Dept.of Internal Med. Cincinnati Ohio 45219 United States Details
Cleveland Clinic Foundation CCF Cleveland Ohio 44195 United States Details
Northwest Cancer Specialists Compass Oncology -BKM Portland Oregon 97210 United States Details
Cancer Centers of the Carolinas CC of C -Eastside Greenville South Carolina 29605 United States Details
Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology Chattanooga Tennessee 37404 United States Details
Tennessee Oncology Dept. of Centennial Medical Nashville Tennessee 37203 United States Details
Texas Cancer Center ( Medical City Dallas Hospital) Dallas Texas 75230 United States Details
Cancer Care Centers of South Texas HOAST CCC of So.TX- Medical Center San Antonio Texas 78229 United States Details
Tyler Cancer Center Tyler Texas 75702 United States Details
Utah Cancer Specialists Salt Lake City Utah 84106 United States Details
Novartis Investigative Site Caba Buenos Aires C1221ADC Argentina Details
Novartis Investigative Site La Plata Buenos Aires B1902AVG Argentina Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Wien A-1090 Austria Details
Novartis Investigative Site Bruxelles 1000 Belgium Details
Novartis Investigative Site Charleroi 6000 Belgium Details
Novartis Investigative Site Gent 9000 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Yvoir 5530 Belgium Details
Novartis Investigative Site Brasilia DF 70330-150 Brazil Details
Novartis Investigative Site Curitiba PR 80060-900 Brazil Details
Novartis Investigative Site Rio de Janeiro RJ 20211-030 Brazil Details
Novartis Investigative Site Campinas SP 13083-970 Brazil Details
Novartis Investigative Site Jau SP 17210-080 Brazil Details
Novartis Investigative Site Sao Paulo SP 05403 000 Brazil Details
Novartis Investigative Site São Paulo SP 01224-000 Brazil Details
Novartis Investigative Site São Paulo SP 01401-901 Brazil Details
Novartis Investigative Site Vancouver British Columbia V5Z 4E3 Canada Details
Novartis Investigative Site Vancouver British Columbia V5Z 4E6 Canada Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Quebec G1J 1Z4 Canada Details
Novartis Investigative Site Quebec G1R 2J6 Canada Details
Novartis Investigative Site Bogota Cundinamarca 110111 Colombia Details
Novartis Investigative Site Bogota 110001 Colombia Details
Novartis Investigative Site Praha 2 Czech Republic 128 20 Czechia Details
Novartis Investigative Site Olomouc CZE 775 20 Czechia Details
Novartis Investigative Site Copenhagen DK-2100 Denmark Details
Novartis Investigative Site Vejle DK-7100 Denmark Details
Novartis Investigative Site Cairo Egypt Details
Novartis Investigative Site HUS Helsinki FIN-00029 Finland Details
Novartis Investigative Site Turku FIN-20521 Finland Details
Novartis Investigative Site Paris Cedex 10 Cedex 10 75475 France Details
Novartis Investigative Site Caen Cedex 14033 France Details
Novartis Investigative Site Saint Priest en Jarez Loire 42270 France Details
Novartis Investigative Site Angers Cedex 1 49033 France Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Creteil 94010 France Details
Novartis Investigative Site Grenoble 38043 France Details
Novartis Investigative Site Lille 59037 France Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Nantes 44035 France Details
Novartis Investigative Site Nice Cedex 06202 France Details
Novartis Investigative Site Pierre Benite Cedex 69495 France Details
Novartis Investigative Site Poitiers 86000 France Details
Novartis Investigative Site Rennes 35019 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Vandoeuvre les Nancy 54511 France Details
Novartis Investigative Site Mannheim Baden-Wuerttemberg 68305 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Duesseldorf 40225 Germany Details
Novartis Investigative Site Eisenach 99817 Germany Details
Novartis Investigative Site Frankfurt 60590 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Kiel 24105 Germany Details
Novartis Investigative Site Koeln 50937 Germany Details
Novartis Investigative Site Leipzig 04103 Germany Details
Novartis Investigative Site Muenchen 81675 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Budapest 1097 Hungary Details
Novartis Investigative Site Alessandria AL 15100 Italy Details
Novartis Investigative Site Ancona AN 60126 Italy Details
Novartis Investigative Site Bergamo BG 24127 Italy Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Catania CT 95123 Italy Details
Novartis Investigative Site Firenze FI 50134 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Pescara PE 65124 Italy Details
Novartis Investigative Site Pisa PI 56126 Italy Details
Novartis Investigative Site Pavia PV 27100 Italy Details
Novartis Investigative Site Reggio Calabria RC 89124 Italy Details
Novartis Investigative Site Roma RM 00133 Italy Details
Novartis Investigative Site Roma RM 00144 Italy Details
Novartis Investigative Site Roma RM 00161 Italy Details
Novartis Investigative Site Siena SI 53100 Italy Details
Novartis Investigative Site Udine UD 33100 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Napoli 80132 Italy Details
Novartis Investigative Site Perugia 06129 Italy Details
Novartis Investigative Site Nagoya Aichi 453-8511 Japan Details
Novartis Investigative Site Nagoya Aichi 466 8560 Japan Details
Novartis Investigative Site Maebashi city Gunma 371 8511 Japan Details
Novartis Investigative Site Maebashi Gunma 371-0821 Japan Details
Novartis Investigative Site Sapporo city Hokkaido 060 8648 Japan Details
Novartis Investigative Site Sapporo Hokkaido 003-0006 Japan Details
Novartis Investigative Site Nishinomiya Hyogo 663 8501 Japan Details
Novartis Investigative Site Tsukuba city Ibaraki 305-8576 Japan Details
Novartis Investigative Site Kanazawa-city Ishikawa 920-8641 Japan Details
Novartis Investigative Site Kumamoto City Kumamoto 860-8556 Japan Details
Novartis Investigative Site Tsu-city Mie 514-8507 Japan Details
Novartis Investigative Site Nagasaki-city Nagasaki 852-8501 Japan Details
Novartis Investigative Site Osaka Sayama Osaka 589 8511 Japan Details
Novartis Investigative Site Suita city Osaka 565 0871 Japan Details
Novartis Investigative Site Hidaka-city Saitama 350-1298 Japan Details
Novartis Investigative Site Hamamatsu-city Shizuoka 431-3192 Japan Details
Novartis Investigative Site Shimotsuke Tochigi 329-0498 Japan Details
Novartis Investigative Site Bunkyo ku Tokyo 113 8655 Japan Details
Novartis Investigative Site Bunkyo-ku Tokyo 113-8519 Japan Details
Novartis Investigative Site Chuo ku Tokyo 104 0045 Japan Details
Novartis Investigative Site Shinagawa ku Tokyo 141 8625 Japan Details
Novartis Investigative Site Shinjuku-ku Tokyo 160 8582 Japan Details
Novartis Investigative Site Shinjuku-ku Tokyo 160-0023 Japan Details
Novartis Investigative Site Akita 010-8543 Japan Details
Novartis Investigative Site Chiba 260 8677 Japan Details
Novartis Investigative Site Hiroshima 734-8551 Japan Details
Novartis Investigative Site Niigata 951 8520 Japan Details
Novartis Investigative Site Osaka 545-8586 Japan Details
Novartis Investigative Site Saitama 330 8503 Japan Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Seoul Seocho Gu 06591 Korea, Republic of Details
Novartis Investigative Site Jeollanam-do 519763 Korea, Republic of Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 06351 Korea, Republic of Details
Novartis Investigative Site Taegu 41944 Korea, Republic of Details
Novartis Investigative Site Selangor 68000 Malaysia Details
Novartis Investigative Site Mexico Distrito Federal 06726 Mexico Details
Novartis Investigative Site Monterrey Nuevo Leon 64460 Mexico Details
Novartis Investigative Site Amsterdam 1081 HV Netherlands Details
Novartis Investigative Site Oslo NO-0310 Norway Details
Novartis Investigative Site Trondheim 7006 Norway Details
Novartis Investigative Site Katowice 40032 Poland Details
Novartis Investigative Site Lublin 20-081 Poland Details
Novartis Investigative Site Rzeszow 35 055 Poland Details
Novartis Investigative Site Warszawa 02-097 Poland Details
Novartis Investigative Site Wroclaw 50-367 Poland Details
Novartis Investigative Site Moscow 125167 Russian Federation Details
Novartis Investigative Site Novosibirsk 630051 Russian Federation Details
Novartis Investigative Site Saint Petersburg 197022 Russian Federation Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 169608 Singapore Details
Novartis Investigative Site Bratislava Slovak Republic 833 10 Slovakia Details
Novartis Investigative Site Bratislava 85107 Slovakia Details
Novartis Investigative Site Bloemfontein 9301 South Africa Details
Novartis Investigative Site Cape Town 7925 South Africa Details
Novartis Investigative Site Parktown 2193 South Africa Details
Novartis Investigative Site Pretoria 0001 South Africa Details
Novartis Investigative Site Pretoria 0027 South Africa Details
Novartis Investigative Site Elche Alicante 03203 Spain Details
Novartis Investigative Site Granada Andalucia 18014 Spain Details
Novartis Investigative Site Malaga Andalucia 29010 Spain Details
Novartis Investigative Site Santander Cantabria 39008 Spain Details
Novartis Investigative Site Salamanca Castilla Y Leon 37007 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Valencia Comunidad Valenciana 46010 Spain Details
Novartis Investigative Site La Coruna Galicia 15006 Spain Details
Novartis Investigative Site Santiago de Compostela Galicia 15706 Spain Details
Novartis Investigative Site Bilbao Pais Vasco 48013 Spain Details
Novartis Investigative Site San Sebastian Pais Vasco 20080 Spain Details
Novartis Investigative Site La Laguna Santa Cruz De Tenerife 38320 Spain Details
Novartis Investigative Site Madrid 28006 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28046 Spain Details
Novartis Investigative Site Zaragoza 50009 Spain Details
Novartis Investigative Site Göteborg SE-413 45 Sweden Details
Novartis Investigative Site Huddinge SE-14186 Sweden Details
Novartis Investigative Site Lulea SE 971 80 Sweden Details
Novartis Investigative Site Lund SE-221 85 Sweden Details
Novartis Investigative Site Orebro SE-701 85 Sweden Details
Novartis Investigative Site Stockholm SE-171 76 Sweden Details
Novartis Investigative Site Sundsvall SE-851 86 Sweden Details
Novartis Investigative Site Umeå SE-901 85 Sweden Details
Novartis Investigative Site Uppsala SE-751 85 Sweden Details
Novartis Investigative Site Geneve 1205 Switzerland Details
Novartis Investigative Site Kaohsiung City 83301 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Taoyuan 33305 Taiwan Details
Novartis Investigative Site Bangkok 10330 Thailand Details
Novartis Investigative Site Bangkok 10400 Thailand Details
Novartis Investigative Site Bangkok 10700 Thailand Details
Novartis Investigative Site Istanbul TUR 34098 Turkey Details
Novartis Investigative Site Adana 01330 Turkey Details
Novartis Investigative Site Ankara 06500 Turkey Details
Novartis Investigative Site Izmir 35340 Turkey Details
Novartis Investigative Site Glasgow G12 OYN United Kingdom Details
Novartis Investigative Site Leeds LS9 7TF United Kingdom Details
Novartis Investigative Site Liverpool L7 8XP United Kingdom Details
Novartis Investigative Site London W12 0HS United Kingdom Details
Novartis Investigative Site Nottingham NG5 1PB United Kingdom Details
Novartis Investigative Site Caracas Distrito Capital 1010 Venezuela Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field